查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418431

皮灰指甲治疗市场报告：2030 年趋势、预测与竞争分析

Dermatophytic Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

皮灰指甲治疗的趋势与预测

到 2030 年，全球皮灰指甲治疗市场预计将达到 45 亿美元，2024 年至 2030 年复合年增长率为 4.5%。这个市场的主要驱动因素是由于灰指甲患者数量的增加、老年人口的增加、研究的不断增加、指甲油的快速普及以及新学名药的快速推出而导致甲癣发病率的增加。全球皮癣菌灰指甲治疗市场的未来看起来充满希望，处方药和成药药市场都有机会。

皮癣菌灰指甲治疗市场洞察

Lucintel 预测，由于 Jubria 的采用率不断提高，指甲彩绘将在预测期内继续成为较大的细分市场。

在这个市场中，成药仍将是一个很大的细分市场，环吡酮的销售将激增。

由于甲癣治疗处方数量不断增加，北美仍是预测期内最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球皮癣菌甲癣治疗市场预计将达到 45 亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球皮癣菌甲癣治疗市场预计将以4.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动因素是糖尿病发病率的增加、老年人口的增加、研究的不断增加、指甲油的迅速普及以及新学名药的快速推出，导致指甲真菌感染疾病的发病率不断增加。

Q4.市场的主要细分市场是什么？

A4. 皮癣菌灰指甲药物市场前景广阔，处方药和成药市场都有机会。

Q5. 市场上主要企业有哪些？

A5. 生产甲癣治疗药物的主要企业如下。

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于 Jublia 的采用率不断提高，指甲油在预测期内仍将占据更大的市场份额。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于甲癣治疗处方数量的增加，北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球皮癣菌灰指甲治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球皮肤丝状菌症灰指甲治疗市场趋势（2018-2023）和预测（2024-2030）
  • 全球皮癣菌灰指甲治疗市场，依产品类型
    • 药片
    • 指甲油
  • 全球皮癣菌灰指甲治疗市场，依给药途径
    • 口服
    • 局部的
  • 全球皮癣菌灰指甲治疗市场，依类型
    • 指定的
    • 在商店
  • 全球皮癣菌灰指甲治疗市场，依销售管道
    • 医院药房
    • 零售药房
    • 线上通路

第四章 2018-2030年区域市场趋势及预测分析

  • 全球皮肤丝状菌症灰指甲治疗市场（按地区）
  • 北美皮癣菌灰指甲治疗市场
  • 欧洲皮癣菌灰指甲治疗市场
  • 亚太皮皮肤丝状菌症灰指甲治疗市场
  • 其他地区皮癣菌灰指甲治疗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球皮癣菌灰指甲治疗市场成长机会
    • 按途径的全球皮灰指甲治疗市场成长机会
    • 全球皮灰指甲治疗市场成长机会（按类型）
    • 全球皮灰指甲治疗市场成长机会（按分销管道）
    • 全球皮灰指甲治疗市场按地区成长机会
  • 全球皮灰指甲治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球皮癣菌灰指甲治疗市场的产能
    • 全球皮癣菌灰指甲治疗市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals
简介目录

Dermatophytic Onychomycosis Treatment Trends and Forecast

The future of the global dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets. The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

A more than 150-page report is developed to help in your business decisions.

Dermatophytic Onychomycosis Treatment by Segment

The study includes a forecast for the global dermatophytic onychomycosis treatment by product type, route of administration, type, distribution channel, and region.

Dermatophytic Onychomycosis Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Tablets
  • Nail Paints

Dermatophytic Onychomycosis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Topical

Dermatophytic Onychomycosis Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prescribed
  • Over-The-Counter

Dermatophytic Onychomycosis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels

Dermatophytic Onychomycosis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Dermatophytic Onychomycosis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dermatophytic onychomycosis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dermatophytic onychomycosis treatment companies profiled in this report include-

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Dermatophytic Onychomycosis Treatment Market Insights

Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Within this market, over-the-counter will remain the larger segment due to rapidly increasing ciclopirox sales.

North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Features of the Global Dermatophytic Onychomycosis Treatment Market

Market Size Estimates: Dermatophytic onychomycosis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dermatophytic onychomycosis treatment market size by various segments, such as by product type, route of administration, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Dermatophytic onychomycosis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, route of administration, type, distribution channel, and regions for the dermatophytic onychomycosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dermatophytic onychomycosis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the dermatophytic onychomycosis treatment market size?

Answer: The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030.

Q2. What is the growth forecast for dermatophytic onychomycosis treatment market?

Answer: The global dermatophytic onychomycosis treatment market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the dermatophytic onychomycosis treatment market?

Answer: The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

Q4. What are the major segments for dermatophytic onychomycosis treatment market?

Answer: The future of the dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets.

Q5. Who are the key dermatophytic onychomycosis treatment market companies?

Answer: Some of the key dermatophytic onychomycosis treatment companies are as follows.

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Q6. Which dermatophytic onychomycosis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Q7. In dermatophytic onychomycosis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the dermatophytic onychomycosis treatment market by product type (tablets and nail paints), route of administration (oral and topical), type (prescribed and over-the-counter), distribution channel (hospital pharmacies, retail pharmacies, and online channels), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dermatophytic Onychomycosis Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Dermatophytic Onychomycosis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Dermatophytic Onychomycosis Treatment Market by Product Type
    • 3.3.1: Tablets
    • 3.3.2: Nail Paints
  • 3.4: Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Topical
  • 3.5: Global Dermatophytic Onychomycosis Treatment Market by Type
    • 3.5.1: Prescribed
    • 3.5.2: Over-the-Counter
  • 3.6: Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
    • 3.6.1: Hospital Pharmacies
    • 3.6.2: Retail Pharmacies
    • 3.6.3: Online Channels

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Dermatophytic Onychomycosis Treatment Market by Region
  • 4.2: North American Dermatophytic Onychomycosis Treatment Market
    • 4.2.2: North American Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.3: European Dermatophytic Onychomycosis Treatment Market
    • 4.3.1: European Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.3.2: European Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.4: APAC Dermatophytic Onychomycosis Treatment Market
    • 4.4.1: APAC Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.4.2: APAC Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.5: ROW Dermatophytic Onychomycosis Treatment Market
    • 4.5.1: ROW Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.5.2: ROW Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Type
    • 6.1.4: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Dermatophytic Onychomycosis Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Dermatophytic Onychomycosis Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dermatophytic Onychomycosis Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bausch Health Companies
  • 7.2: Pfizer
  • 7.3: Galderma
  • 7.4: GlaxoSmithKline
  • 7.5: Janssen Pharmaceuticals
  • 7.6: Cipla
  • 7.7: Kaken Pharmaceuticals